Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | 0.10% | 125.14 | 0.0% | $2517.24m | |
| BNGO | BioNano Genomics, Inc. | -11.93% | 8.05 | 0.0% | $1626.30m | |
| GILD | Gilead Sciences, Inc. | 1.37% | 67.99 | 1.0% | $696.88m | |
| AMGN | Amgen, Inc. | 1.65% | 252.36 | 1.3% | $574.64m | |
| CRSP | CRISPR Therapeutics AG | -4.30% | 189.77 | 0.6% | $516.52m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 1.57% | 542.27 | 2.7% | $477.27m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -0.61% | 157.74 | 2.0% | $471.04m | |
| NVAX | Novavax, Inc. | -2.31% | 125.05 | 92.9% | $463.88m | |
| ILMN | Illumina, Inc. | 3.42% | 403.54 | 3.5% | $395.72m | |
| SRPT | Sarepta Therapeutics, Inc. | -0.04% | 96.76 | 13.8% | $351.95m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 2.07% | 236.70 | 1.9% | $351.25m | |
| BIIB | Biogen, Inc. | -1.30% | 270.28 | 1.7% | $328.68m | |
| BNTX | BioNTech SE | -1.40% | 103.23 | 0.0% | $308.28m | |
| OCGN | Ocugen, Inc. | -4.70% | 2.23 | 0.0% | $294.71m | |
| PACB | Pacific Biosciences of California, Inc. | -4.02% | 38.59 | 7.4% | $258.16m |
Company Profile
Cyclacel Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It uses cell cycle, transcriptional regulation and DNA damage response biology to develop medicines for cancer and other proliferative diseases. The company builds a biopharmaceutical business, which is focused in hematology and oncology based on a pipeline of novel drug candidates. Its products include CYC065, seliciclib, and sapacitabine. The company was founded by Ronald J. Berenson, David Philip Lane, and David Glover on August 13, 1996 and is headquartered in Berkeley Heights, NJ.